CareDx

What is CareDx?

CareDx is a company within the Healthcare category. CareDx is a precision medicine company specialized in the discovery, development, and commercialization of high-value diagnostic solutions for transplant patients and caregivers. It provides a suite of genomics-based information through its laboratory services and digital health tools to manage the lifelong journey of transplant recipients.

When was CareDx founded and where is it based?

CareDx was founded in 1998 and is headquartered in Brisbane, California, USA.

What is CareDx's Brand Authority Index tier?

CareDx is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.

How accurately do AI models describe CareDx?

AI narrative accuracy for CareDx is Moderate. Significant factual deltas detected. Inconsistent representation across models.

How do AI models position CareDx competitively?

AI models classify CareDx as a Challenger. AI names competitors first.

How visible is CareDx in buyer-intent AI queries?

CareDx appeared in 6 of 7 sampled buyer-intent queries (86%). CareDx dominates for high-intent branded queries and specific product queries, but faces stiff competition from Natera for broader 'dd-cfDNA transplant' queries.

What do AI models currently say about CareDx?

AI reliably identifies the brand's core medical niche and primary product lines. However, it may lag on recent legal developments (patent litigation or DOJ inquiries) and the full breadth of its digital health ecosystem. Key gap: AI often treats CareDx solely as a diagnostics lab, frequently overlooking its 'Digital Health' and 'Patient Care' service divisions which are a growing part of the business model.

How many facts about CareDx are well-documented vs need fixing vs retrieval-dependent?

Of 5 key facts verified about CareDx, 3 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.

What is CareDx's biggest AI narrative vulnerability?

The transition from a pure-play diagnostic company to a 'multimodality' transplant company is often missed or undersold.

What questions do buyers ask AI about CareDx?

Buyers evaluating CareDx typically ask AI models about "non-invasive transplant rejection monitoring", "AlloSure heart test medical info", "dd-cfDNA testing for kidney transplant", and 4 similar queries.

What does CareDx offer?

CareDx's core products are AlloSure, AlloMap, AlloCare, UroMap, HeartCare, KidneyCare.

How is CareDx priced?

CareDx uses Usage-based (Insurance/Medicare Reimbursement).

Who does CareDx target?

CareDx serves Transplant surgeons, nephrologists, cardiologists, and transplant recipients..

What differentiates CareDx from competitors?

CareDx The only company offering a truly integrated, multimodality transplant ecosystem combining genomics, digital tools, and pharmacy services.

Verified from CareDx website

Founded: 1998

Headquarters: Brisbane, California

Problems this brand solves

• Manual Clinical Monitoring: Clinicians manually monitoring patient vitals and standard lab results (creatinine, etc.) to guess at organ stability.

Buyers search for

• non-invasive transplant rejection monitoring
• AlloSure heart test medical info
• dd-cfDNA testing for kidney transplant
• transplant patient management software
• best pharmacy for transplant medications
• Standard Standard of Care Lab Testing: Reliance on traditional, less sensitive biopsy procedures or basic blood chemistry without molecular profiling.
• Generic Diagnostic Labs: Using generic pathology labs that do not specialize in transplant-specific molecular diagnostics.